| __timestamp | Ionis Pharmaceuticals, Inc. | Perrigo Company plc |
|---|---|---|
| Wednesday, January 1, 2014 | 20140000 | 675200000 |
| Thursday, January 1, 2015 | 37173000 | 771800000 |
| Friday, January 1, 2016 | 48616000 | 1205500000 |
| Sunday, January 1, 2017 | 108488000 | 1146500000 |
| Monday, January 1, 2018 | 244622000 | 1125800000 |
| Tuesday, January 1, 2019 | 287000000 | 1166100000 |
| Wednesday, January 1, 2020 | 354000000 | 1175500000 |
| Friday, January 1, 2021 | 186000000 | 1111400000 |
| Saturday, January 1, 2022 | 151000000 | 1210100000 |
| Sunday, January 1, 2023 | 232600000 | 1274600000 |
Igniting the spark of knowledge
In the competitive landscape of pharmaceuticals, understanding the efficiency of Selling, General, and Administrative (SG&A) expenses is crucial. Ionis Pharmaceuticals, Inc. and Perrigo Company plc, two industry giants, have shown contrasting trends over the past decade.
From 2014 to 2023, Ionis Pharmaceuticals saw a significant increase in SG&A expenses, peaking in 2020 with a 1,660% rise from 2014. However, a notable dip occurred in 2021, reflecting strategic cost management.
Perrigo, on the other hand, maintained a more stable SG&A trajectory, with expenses growing by approximately 89% over the same period. This stability suggests a consistent approach to managing operational costs.
While Ionis shows dynamic shifts, Perrigo's steadiness highlights different strategic priorities. Investors and analysts should consider these trends when evaluating operational efficiency and long-term sustainability.
SG&A Efficiency Analysis: Comparing Johnson & Johnson and Perrigo Company plc
Cost Management Insights: SG&A Expenses for Alnylam Pharmaceuticals, Inc. and Ionis Pharmaceuticals, Inc.
Selling, General, and Administrative Costs: Alnylam Pharmaceuticals, Inc. vs Perrigo Company plc
Comparing SG&A Expenses: Walgreens Boots Alliance, Inc. vs Ionis Pharmaceuticals, Inc. Trends and Insights
Corcept Therapeutics Incorporated and Perrigo Company plc: SG&A Spending Patterns Compared
Ionis Pharmaceuticals, Inc. vs Apellis Pharmaceuticals, Inc.: SG&A Expense Trends
SG&A Efficiency Analysis: Comparing Ionis Pharmaceuticals, Inc. and MorphoSys AG
Cost Management Insights: SG&A Expenses for Ionis Pharmaceuticals, Inc. and Travere Therapeutics, Inc.
Selling, General, and Administrative Costs: Ionis Pharmaceuticals, Inc. vs Xencor, Inc.
Axsome Therapeutics, Inc. or Perrigo Company plc: Who Manages SG&A Costs Better?
Viking Therapeutics, Inc. and Perrigo Company plc: SG&A Spending Patterns Compared
SG&A Efficiency Analysis: Comparing Perrigo Company plc and Supernus Pharmaceuticals, Inc.